Validation of pncA Gene Sequencing in Combination with the Mycobacterial Growth Indicator Tube Method To Test Susceptibility of Mycobacterium tuberculosis to Pyrazinamide

Initial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic Review and Meta-analysis

(2013) Woojin Lew et al.   ANNALS OF INTERNAL MEDICINE

Pyrazinamide Susceptibility Testing in Mycobacterium tuberculosis: a Systematic Review with Meta-Analyses

(2011) Kwok Chiu Chang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis

(2011) W. Shi et al.   SCIENCE

Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains

(2010) Ida Parwati et al.   LANCET INFECTIOUS DISEASES

Quantitative Drug Susceptibility Testing of Mycobacterium tuberculosis by Use of MGIT 960 and EpiCenter Instrumentation

(2009) B. Springer et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Potential for Erroneous Results Indicating Resistance When Using the Bactec MGIT 960 System for Testing Susceptibility ofMycobacterium tuberculosisto Pyrazinamide

(2009) Pamela Chedore et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Mycobacterium tuberculosis Genotypic Diversity in Pyrazinamide-Resistant Isolates of Iran

(2009) Farahnoosh Doustdar et al.   Microbial Drug Resistance

Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand

(2009) Sushil Pandey et al.   PATHOLOGY

Pyrazinamide Resistance among South African Multidrug-Resistant Mycobacterium tuberculosis Isolates

(2008) M. Mphahlele et al.   JOURNAL OF CLINICAL MICROBIOLOGY